Xiang-Dong Wang
Overview
Explore the profile of Xiang-Dong Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
198
Citations
2692
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang C, Long Z, Wang X, Kong Y, Zhou L, Jia W, et al.
Front Neuroinform
. 2025 Feb;
19:1544372.
PMID: 40012766
Objective: NIHSS for stroke is widely used in clinical, but it is complex and subjective. The purpose of the study is to present a quantitative evaluation method of stroke association...
2.
Zeng X, Varady K, Wang X, Targher G, Byrne C, Tayyem R, et al.
Metabolism
. 2024 Sep;
161:156028.
PMID: 39270816
Metabolic dysfunction-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD), has become the leading cause of chronic liver disease worldwide. Optimal dietary intervention strategies for MAFLD are...
3.
Cui T, Guo X, Li B, Wang Z, Xiao N, Liu F, et al.
J Contemp Brachytherapy
. 2024 May;
16(2):121-127.
PMID: 38808212
Purpose: Few studies have focused on the management of inoperable ampullary carcinoma (AC), and patients with jaundice suffer from biliary stents replacement frequently. Iodine-125 (I) brachytherapy has been used in...
4.
Tang Y, Luo X, Wang X
World Psychiatry
. 2024 May;
23(2):295-296.
PMID: 38727059
No abstract available.
5.
Liu F, Wang Z, Li M, Zhang X, Cai F, Wang X, et al.
Health Inf Sci Syst
. 2024 Apr;
12(1):29.
PMID: 38584761
Purpose: To explore the biliary and duodenal microbiota features associated with the formation and recurrence of choledocholithiasis (CDL). Methods: We prospectively recruited patients with primary (P-CDL, n = 29) and...
6.
Peng C, Zhao Y, Li F, Guo T, Wang X, Wang B, et al.
Neurocrit Care
. 2024 Jan;
41(1):119-128.
PMID: 38253923
Background: The differences in outcomes after aneurysmal subarachnoid hemorrhage (aSAH) between the sexes have not been concretely determined. This study aimed to evaluate the differences in epidemiology, outcomes, and risk...
7.
Wang X, Ge N, Yang Y
World J Gastrointest Surg
. 2024 Jan;
15(12):2926-2931.
PMID: 38222008
Background: Marked arterioportal shunt (APS) can be a contraindication for transarterial radioembolization (TARE) because of the risk of radiation-induced liver toxicity or pneumonitis. To date, the best method to close...
8.
Dabbagh Moghaddam F, Dadgar D, Esmaeili Y, Babolmorad S, Ilkhani E, Rafiee M, et al.
Environ Res
. 2023 Sep;
237(Pt 2):117084.
PMID: 37683792
The most important reason for death from ovarian cancer is the late diagnosis of this disease. The standard treatment of ovarian cancer includes surgery and chemotherapy based on platinum, which...
9.
Cai Q, Yang P, Yang X, Zhang X, Guo L, Lu X, et al.
Cancer
. 2023 Jul;
129(19):2999-3009.
PMID: 37449788
Background: The role of carbohydrate antigen 19-9 (CA 19-9) in response assessment among patients with intrahepatic cholangiocarcinoma (iCCA) remains unknown. The authors studied the association of the CA 19-9 response...
10.
Makvandi P, Song H, Yiu C, Sartorius R, Zare E, Rabiee N, et al.
Mil Med Res
. 2023 Jul;
10(1):30.
PMID: 37438838
No abstract available.